![Hiroyuki Fukase](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 2 Mio $ am 30.06.2026
Hiroyuki Fukase currently works at Icross Co., Ltd., as President & Representative Director from 2019 and Clinical Research Hospital Tokyo, as Manager-Clinical Research Center from 2017.
Mr. Fukase also formerly worked at I'rom Group Co., Ltd., as Executive Officer & Chief Medical Officer from 2017 to 2018.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Shin Nippon Biomedical Laboratories, Ltd.
 Shin Nippon Biomedical Laboratories, Ltd. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services 0,6 % | 31.03.2025 | 250 000 ( 0,6 % ) | 2 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Clinical Research Hospital Tokyo | Corporate Officer/Principal | 01.10.2017 |
Icross Co., Ltd.
 Icross Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in physician-led clinical trials and clinical research support | Präsident | 01.06.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| I'ROM GROUP CO., LTD. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
I'rom Group Co., Ltd.
 I'rom Group Co., Ltd. Medical/Nursing ServicesHealth Services Provides clinical research services and other support services for the medical industry | Health Services |
Clinical Research Hospital Tokyo | |
Icross Co., Ltd.
Icross Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in physician-led clinical trials and clinical research support | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
